Segment Information (Tables)

6 Months Ended

Mar. 31, 2021

Segment Reporting [Abstract]

Segment Revenue, Operating Income (Loss) and Depreciation and Amortization

Segment revenue, operating income (loss), and depreciation and amortization were as follows:

	Three Months Ended						Six Months Ended
	March 31,						March 31,
(In thousands)	2021			2020			2021			2020
Revenue:
Medical Device	$	27,907		$	16,304		$	44,103		$	33,708
In Vitro Diagnostics		7,088			6,518			13,189			11,730
Total revenue	$	34,995		$	22,822		$	57,292		$	45,438
Operating income (loss):
Medical Device	$	8,564		$	(1,453	)	$	7,971		$	(1,876	)
In Vitro Diagnostics		3,809			3,462			7,029			6,061
Total segment operating income		12,373			2,009			15,000			4,185
Corporate		(2,890	)		(2,165	)		(5,424	)		(4,607	)
Total operating income (loss)	$	9,483		$	(156	)	$	9,576		$	(422	)
Depreciation and amortization:
Medical Device	$	1,721		$	1,439		$	3,373		$	2,894
In Vitro Diagnostics		88			109			193			219
Corporate		97			248			200			487
Total depreciation and amortization	$	1,906		$	1,796		$	3,766		$	3,600